Qritive Pte. Ltd. is engaged in the development and deployment of AI-powered digital pathology and cancer diagnostics solutions. The company specializes in offering both a scalable digital pathology platform (Pantheon™) and clinically validated AI modules for detecting, grading, and classifying cancers including prostate, colon, breast, lymph node metastasis, and biomarker analysis. It was incorporated in 2017 and is based in Singapore.
Headquarters
114 Lavender Street, #11-83, CT Hub 2, Singapore 338729
Singapore; Singapore;
Contact Details: Purchase the Qritive Pte. Ltd. report to view the information.
Website: https://qritive.com
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service